P

Inventor

BOSSLET KLAUS

DE44 patents
⚠️ This page may combine multiple inventors who share the name “BOSSLET KLAUS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BEHRINGWERKE AG

15 patents
US5591828AJan 7, 1997

Bispecific and oligospecific mono-and oligovalent receptors, the preparation and use thereof

BEHRINGWERKE AG622 citations98
US5621002AApr 15, 1997

Prodrugs for enzyme mediated activation

BEHRINGWERKE AG217 citations97
US5710134AJan 20, 1998

Combination of necrosis-inducing substances with substances which are activated by necroses for the selective therapy of tumors and inflammatory disorders

BEHRINGWERKE AG54 citations96
US5955100ASep 21, 1999

Prodrugs their preparation and use as pharmaceuticals

BEHRINGWERKE AG75 citations95
US7060495B2Jun 13, 2006

Fusion proteins for prodrug activation

BEHRINGWERKE AG30 citations92
US5877158AMar 2, 1999

Pro-prodrugs, their production and use

BEHRINGWERKE AG45 citations92
US5643731AJul 1, 1997

Use of pairs of leucine zipper peptides in immunoassay methods

BEHRINGWERKE AG21 citations92
US5645817AJul 8, 1997

Granulocyte-binding antibody constructs, their preparation and use

BEHRINGWERKE AG11 citations74
US5639621AJun 17, 1997

Monoclonal antibodies against tumor-associated antigens

BEHRINGWERKE AG7 citations73
US5686583ANov 11, 1997

Specific antibodies against activated platelets, the preparation thereof and the use thereof in diagnosis and therapy

BEHRINGWERKE AG14 citations72
US5639622AJun 17, 1997

Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof

BEHRINGWERKE AG6 citations71
US5730981AMar 24, 1998

Monoclonal anti-ganglioside antibody and its preparation

BEHRINGWERKE AG6 citations68
US5849799ADec 15, 1998

Use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases

BEHRINGWERKE AG2 citations62
US5695758ADec 9, 1997

Monoclonal antibodies against tumor-associated antigens, processes for the preparation thereof and the use thereof

BEHRINGWERKE AG2 citations62
US5674994AOct 7, 1997

Polynucleotides encoding the anti-PEM antibody BW835 variable domains and expression vectors

BEHRINGWERKE AG1 citations62

HOECHST AG

5 patents

AVENTIS PHARMA GMBH

5 patents

BEHRING DIAGNOSTICS GMBH

3 patents

DADE BEHRING MARBURG GMBH

3 patents

SCHERING AG

2 patents

(unassigned)

2 patents

BEHRINGWERKE AKTIENGELLSCHAFT

1 patent

HOECHST LAB

1 patent

HOECHST MARION ROUSSEL DE GMBH

1 patent

BENES IVAN

1 patent

SANOFI AVENTIS DEUTSCHLAND

1 patent

SANOFI AVENTIS PHARMA DEUTSCHL

1 patent

BEHRINWERKE AG

1 patent

BAYER SCHERING PHARMA AG

1 patent

BOSSLET KLAUS

1 patent